The main recommendations of the Guideline include:
- The Task Force recommends against cervical cancer screening (with Pap tests) for women aged younger than 25 because minimal or no benefit was found to outweigh the potential harms in this group.
- The Task Force found moderate quality evidence showing that screening with Pap tests may have a small effect in reducing cervical cancer mortality and morbidity among women aged 25-29 and recommends screening these women at intervals of 3 years.
- The Task Force found high quality evidence showing that screening for cervical cancer with Pap tests reduces mortality and morbidity among women aged 30-69, and strongly recommends screening these women at intervals of 3 years.
- Screening may cease in women aged 70 and older, but only after 3 successive negative Pap tests.
For the complete report and details of the recommendations, please visit www.canadiantaskforce.ca
About the Canadian Task Force on Preventive Health Care The Canadian Task Force on Preventive Health Care
has been established to develop clinical practice guidelines that support primary care providers in delivering preventive health care. The mandate of the Task Force is to develop and disseminate clinical practice guidelines for primary and preventive care, based on systematic analysis of scientific evidence.
SOURCE The Canadian Task Force on Preventive Health Care